|
|
Plenary Session History
Premier Lecture Awards
This lecture is awarded in non-election years to a neurologist chosen by the American Academy of Neurology President. In election years this lecture is awarded to the outgoing President of the American Academy of Neurology.
The premier award sponsored by the American Academy of Neurology, this lecture is awarded to a neurologist for excellence in clinically relevant research. The Wartenberg Lecture is presented during the Presidential Plenary Session of the Scientific Program of the American Academy of Neurology Annual Meeting.
This lecture is awarded for excellence in education involved in clinically relevant research. The Merritt lecture is presented every other year during the Presidential Plenary Session of the Scientific Program of the American Academy of Neurology Annual Meeting.
This lecture is awarded is endowed by Roche Pharmaceuticals. This lecture is awarded to a neurologist for excellence in neuroscience and is presented at the Presidential Plenary Session at the Annual Meeting.
Sponsored by the AAN, AAN Foundation, and funded through an anonymous donor, this award recognizes outstanding work by an individual in the field of child neurology/developmental neurobiology. The Carter lecture is presented every other year during the Presidential Plenary Session of the Scientific Program of the American Academy of Neurology Annual Meeting.
This plenary session features translational research related to clinical issues of importance. Four outstanding physician-scientists will provide summaries of their recent research findings and describe the clinical implications of the results.
This plenary session features translational research related to clinical issues of importance. Four outstanding physician-scientists provide summaries of their recent research findings and describe the clinical implications of the results.
This plenary session highlights the issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments. In addition, a case study format addresses topics of interest.
Presidential Plenary Session
Presidential Lecture History
| Year |
Author |
Title of Paper |
| 1998 |
Alan Brinkley, PhD |
Faiths that Failed? Professionalism, Technology and Science in Twentieth Century America |
| 1999 |
Steven P. Ringel, MD |
Practicing Neurology: A Delicate Balance |
| 2000 |
Seymour Benzer, PhD |
Neurology of Drosophila |
| 2001 |
Francis I. Kittredge, Jr., MD |
Challenges for Neurological Care: 2001-2030 |
| 2002 |
V. S. Ramachandran, MD, PhD |
What Neurology Can Tell Us About Human Nature, Synesthesia and the Meaning of Art |
| 2003 |
Stanley Fahn, MD |
What's New in PD in 2003? |
| 2004 |
Eric R. Kandel, MD |
Molecular Mechanisms for the Persistence of Memory Storage |
| 2005 |
Sandra F. Olson, MD |
Women in Neurology |
| 2006 |
Robert J. Adams, MD |
Small Patients with Big Stroks: The Sickle Cell Story |
| 2007 |
Thomas R. Swift, MD |
Neurology |
| 2008 |
Giacomo Rizzolatti, MD |
The Mirror Neuron System |
Back to top.
Robert Wartenberg Lecture History
| Year |
Author |
Title of Paper |
| 1975 |
Neal S. Miller, MD |
Some Psychosomatic Effects of Learning |
| 1976 |
Professor Roger W. Gilliatt |
The Different Effects of Ischaemia and Compression of Peripheral Nerves |
| 1977 |
William H. Oldendorf, MD |
The Quest for an Image of Brain |
| 1978 |
John Walton, MD |
The Science of Clinical Neurology |
| 1980 |
James Lance, MD |
Muscle Tone, Reflexes and the Control of Movement |
| 1981 |
C. D. Marsden, MD |
The Mysterious Function of the Basal Ganglia |
| 1982 |
Fred Plum, MD |
What Makes the Brain Vulnerable to Ischemia |
| 1983 |
Lewis P. Rowland, MD |
Entering the Era of the Molecular Genetics: Clinical Problems and Prospects |
| 1984 |
Joseph B. Martin, MD |
Huntington's Disease: New approaches to an Old Problem |
| 1985 |
Earl A. Zimmerman, MD |
Brain Peptides: From Neurosecretions to Neuronal Communication and Beyond |
| 1986 |
Stanley Fahn, MD |
The Twists and Turns of Torsion Dystonia |
| 1987 |
Hugo Moser, MD |
The Peroxisome: Nervous System Role of a Previously Underrated Organelle |
| 1988 |
Peter Dyck, MD |
Hypoxic Peripheral Neuropathy |
| 1989 |
Jerome Posner, MD |
Cancer and the Neurologist |
| 1990 |
Robert A. Fishman, MD |
Free Radicals and The Treatment of Brain Injury and Ischemia |
| 1991 |
M. Marsel Mesulam, MD |
Behavioral Neuroanatomy of Cortical Cholinergic Pathways in the Normal and Aging Brain |
| 1992 |
Thomas D. Bird, MD |
The Fascination of Neurogenetics: A Clinician's Perspective |
| 1993 |
Herbert Schaumburg, MD |
The Threat and the Tool |
| 1994 |
Andrew G. Engel, MD |
Congenital Myasthenic Syndromes |
| 1995 |
Sid Gilman, MD |
The Enigma of Multiple System Atrophy |
| 1996 |
John W. Griffin, MD |
Guillain Barre' Syndromes: Imitation as the Sincerest Form of Injury |
| 1997 |
John Mazziotta, MD, PhD |
The Landscape of the Human Nervous System in Health and Disease: Brain Mapping in Five Dimensions |
| 1998 |
Robert C. Griggs, MD |
The Impact of Molecular Discoveries on the Treatment of Neurological Disease |
| 1999 |
Steven Waxman, MD |
The Molecular Revolution and the Preservation of Function in Neurological Disease |
| 2000 |
Roger N. Rosenberg, MD |
The Molecular and Genetic Basis of Alzheimer's Disease - The End of the Beginning |
| 2001 |
Donald L. Price, MD |
Alzheimer's Disease: Lessons from Transgenic and Gene Targeted Models |
| 2002 |
Anne B. Young, MD, PhD |
Clinicopathological Aspects and Genetics of Neurodegeneration |
| 2003 |
John Newsom-Davis, MD, FRS |
Antibody-Mediated Channelopathies at the Neuromuscular Junction and Beyond: New Targets, New Syndromes |
| 2004 |
Huda Y. Zogbhi, MD |
Rett Syndrome and MeCP2 Link Chromatin Remodeling and Neurobehavioral disorders |
| 2005 |
Stanley B. Prusiner, MD |
Synthetic Prions: Diagnosis and Treatment of Prion Disease |
| 2006 |
Mahlon DeLong, MD |
Changing Models of Basal Ganglia Function |
| 2007 |
Robert H. Brown, MD, DPhil |
Amyotrophic Lateral Sclerosis: From Mutations to Mechanisms and Medicines |
| 2008 |
Robert L. MacDonald, MD, PhD |
Molecular Pathogenesis of Genetic Epilepsies Associated with GABAA Receptor Mutations |
Back to top.
H. Houston Merritt (previously Netter) Lecture History
| Year |
Author |
Title of Paper |
| 1987 |
Arthur K. Asbury, MD |
Neuropathies: A Currant Appraisal |
| 1988 |
Robert Joynt, MD |
Thoughts of an Aging Brain on Brain Aging |
| 1989 |
Robert B. Daroff |
Eye Movements in Health and Disease |
| 1990 |
Richard T. Johnson, MD |
Viruses and Human Demyelinating Diseases |
| 1991 |
Not offered |
|
| 1992 |
Not offered |
|
| 1993 |
William Landau, MD |
The Practice of Clinical Neuroskepticism |
| 1994 |
Not offered |
|
| 1995 |
J.P. Mohr, MD |
Reappraisal of Classical Clinicoanatomic Correlations |
| 1996 |
Not offered |
|
| 1997 |
Barry G. Arnason, MD |
Immune System Abnormalities in Multiple Sclerosis and How to Correct Them |
| 1998 |
Not offered |
|
| 1999 |
Timothy A. Pedley, MD |
The Changing Face of Academic Neurology: Implications for Neurologic Education |
| 2000 |
Not offered |
|
| 2001 |
Kathleen M. Foley, MD |
Cancer Pain: Science, Politics and Professionalism |
| 2002 |
Not offered |
|
| 2003 |
David Zee, MD |
Single Case Reports: Windows to Brain Function |
| 2004 |
Not offered |
|
| 2005 |
Ira Shoulson, MD |
Equipoise and the Value of Uncertainty for Randomized Clinical Trials |
| 2006 |
Not offered |
|
| 2007 |
Martin A. Samuels, MD |
Merritt to Voodoo to Takotsubo: A Window into the World of Neuro-Visceral Control |
| 2008 |
Not offered |
|
Back to top.
George C. Cotzias Lecture History
| Year |
Author |
Title of Paper |
| 1978 |
Roger Guillemin, MD |
Brain Peptides in Physiology and Medicine |
| 1979 |
D. Carleton Gajdusek, MD |
Etiology of Transmissible Virus Dementias (KURU and CJD): Unconventional Viruses Viroids or Infectious Membranes |
| 1980 |
Roscoe Brady, MD |
The Control and Therapy of Lipid Storage Disorders Current Status and Future Strategies |
| 1981 |
Marshall Nirenberg, MD |
Molecular Events in Synapse Formation |
| 1982 |
Louis Sokoloff, MD |
Metabolic Mapping of Local Functional Activity in the Central Nervous System of Animals and Man |
| 1983 |
Torsten Wiesel, MD |
Morphological Basis of Visual Cortical Function |
| 1984 |
Eric R. Kandel, MD |
Steps Toward a Molecular Biology of Learning |
| 1985 |
Solomon H. Snyder, MD |
MPTP: A Neurotoxin Providing Molecular Clues to Parkinsonism |
| 1986 |
Michael B. A. Oldstone, MD |
Anatomy of Viral Disease |
| 1987 |
Stanley Prusiner, MD |
Prions - Novel Infectious Pathogens Causing Scrapie and CJD |
| 1988 |
Louis Kunkel, MD |
A Molecular Biological Approach to Neuromuscular Disorders |
| 1989 |
Salvatore DiMauro, MD |
Mitochondrial Diseases of the Nervous System |
| 1990 |
Pasko Rakic, MD |
Specification of Cerebral Cortical Maps |
| 1991 |
Not offered |
|
| 1992 |
William Oldendorf, MD |
The Transition from CT to MRI and Beyond |
| 1993 |
Not offered |
|
| 1994 |
Albert Aguayo, MD |
Enhancing Neuronal Survival and Regrowth after CNS Injury |
| 1995 |
Not offered |
|
| 1996 |
Robert MacDonald, MD, PhD |
Regulation of GABAerie Inhibition in the Treatment of Epilepsy |
| 1997 |
Not offered |
|
| 1998 |
Kenneth H. Fischbeck, MD |
Repeat Expansion Neurodegenerative Disease |
| 1999 |
Not offered |
|
| 2000 |
Howard L. Fields, MD, PhD |
Setting the Stage for Pain |
| 2001 |
Not offered |
|
| 2002 |
Paul Greengard, PhD |
The Neurobiology of Slow Synaptic Transmission |
| 2003 |
Not offered |
|
| 2004 |
William C. Mobley, MD, PhD |
Trafficking the Target ? Derived Signals of Neurotrophic Factors: Implications for Normal and Degenerating Neurons |
| 2005 |
Not offered |
|
| 2006 |
Marcus E. Raichle, MD |
The Visible Brain: An Evolving Perspective |
| 2007 |
Not offered |
|
| 2008 |
Arnold R. Kriegstein, MD, PhD |
The Dynamics of Neural Stem and Progenitor Cells in Cortical Development |
Back to top.
Sidney Carter Award in Child Neurology Award Winner History
| Year |
Winner |
Title of Paper |
| 1998 |
Huda Zoghbi, MD |
Progress in Understanding the Pathogenesis of Dominantly Inherited Ataxias |
| 1999 |
Not offered |
|
| 2000 |
Donna Ferriero, MD |
Injury Response in the Developing Brain: The Search for Age-Appropriate Therapies |
| 2001 |
Not offered |
|
| 2002 |
Scott L. Pomeroy, MD, PhD |
Molecular Genomics of Central Nervous System Embryonal Tumors |
| 2003 |
Not offered |
|
| 2004 |
Gary Clark, MD |
The Roles of Lissencephaly Genes in Brain Development |
| 2005 |
Not offered |
|
| 2006 |
Elizabeth Engle, MD |
Oculomotility Disorders Arising from Disruptions in Brainstem Motoneuron Development |
| 2007 |
Not offered |
|
| 2008 |
Marjo van der Knaap, MD PhD |
Leukoencephalopathies: From MRI Patterns to Disease Genes and Beyond |
Back to top.
Decade of the Brain Lecturer History
| Year |
Author |
Title of Paper |
| 1991 |
J. William Langston |
Parkinson's Disease: The Next Decade of Research |
| 1991 |
Anne B. Young |
Alzheimer's and Huntington's Disease: New Neurobiological Approach |
| 1991 |
Kenneth Fischbeck |
Molecular Genetics of Neuromuscular Disease |
| 1991 |
Dennis W. Choi |
Anti-Excitotoxic Approaches to the Treatment of Hypoxic-Ischemic Neuronal Injury |
| 1991 |
John C. Mazziotta |
Mapping the Brain in Health and Disease: New Tools for the Clinical Neuroscientist in the 90's |
| 1992 |
Robert L. Barchi, MD |
Sodium Channels and Disorders of the Muscle Membrane |
| 1992 |
Marcus E. Raichle |
Functional Brain Images of Normal Human Behavior |
| 1992 |
Lawrence Steinman |
The Development of Selective Therapy for Autoimmune Disease of the Nervous System |
| 1992 |
Dale Purves |
Maps, Modules and the Growth of the Brain |
| 1992 |
Howard Fields |
New Concepts in Neurogenic Pain |
| 1992 |
Anders Bjorklund |
Neural Grafting in Parkinson's Disease: Recent Progress and Future Perspectives |
| 1993 |
Antonio Damasio |
Memory and Language Systems in Humans |
| 1993 |
Carla Shatz |
Order from Disorder in the Development of Connections in the Visual System |
| 1993 |
J. Allan Hobson |
Sleep: Order and Disorder |
| 1993 |
Robert Sloviter |
Basic Mechanisms of Epilepsy |
| 1994 |
Louis J. Ptacek |
Molecular Neurogenetics |
| 1994 |
William Snider |
Regulation of Neuronal Survival by Neurotrophins |
| 1994 |
Richard Frackowiak |
The Adapting Human Brain |
| 1994 |
Senator Tom Harkin |
Biomedical Research and Health Care Reform |
| 1994 |
Albert Galaburda |
Neurobiology of Developmental Dyslexia |
| 1995 |
Michael Moskowitz |
Migraine Enters the Molecular Era |
| 1995 |
Ted Dawson |
Nitric Oxide: A Radical Concept in Neurotransmission and Neurotoxicity |
| 1995 |
Frankie Trull |
Threats Faced by Those Conducting Animal Research |
| 1995 |
Donald Price |
Animal Models in Neurodegenerative Disease: Mechanisms and Therapies |
| 1995 |
Leon Epstein |
HIV-1 Neuropathogenesis |
| 1996 |
Mahlon DeLong |
Parkinson's Disease and the Basal Ganglia: Lessons from the Operating Room |
| 1996 |
Robert H. Brown |
ALS |
| 1996 |
Kevin Campbell |
Molecular Basis of Muscular Dystrophy: Disorders of the Dystrophin-Glycoprotein Complex |
| 1996 |
David Gutmann |
Neurofibromatosis I: From Gene to Function |
| 1997 |
Karen Hsiao, MD, PhD |
Understanding the Biology and Molecular Pathogenesis of Alzheimer's Disease in Transgenic Mice |
| 1997 |
Mark Hallett, MD |
Dystonia: Pathophysiology of a Mysterious Movement Disorder |
| 1997 |
William Mobley, MD |
Neurotrophic Factors in the Clinic: Novel Treatments for Neurologic Disorders? |
| 1997 |
Bruce Ransom, MD, PhD |
New Perspectives on the Physiology and Functions of Glial Cells |
| 1998 |
Fred H. Gage, PhD |
The Promise of Gene Therapy |
| 1998 |
Marc A. Dichter, MD, PhD |
Epileptogenesis: How Does the Brain Develop the Propensity for Seizures? |
| 1998 |
Huda Zoghbi, MD |
Progress in Understanding the Pathogenesis of Dominantly Inherited Ataxias |
| 1998 |
Richard P. Mayeux, MD, MSc |
Translating Genes and Molecules into Risk Factors and Diagnostic Tests |
| 1999 |
Tim Tully, PhD |
Genetic Basis of Memory |
| 1999 |
Jeffrey D. Rothstein, MD PhD |
Stumbling, Shakes and Twitches: Disorders of Glutamate Transport |
| 1999 |
Justin A. Zivin, MD, PhD |
Thrombolytic Stroke Therapy: Past, Present, and Future |
| 1999 |
Kirk C. Wilhelmsen, MD,PhD |
A Century of Progress in Understanding Frontotemporal-Degeneration |
| 2000 |
J. Timothy Greenamyre, MD, PhD |
Environmental Toxins, Mitochondria and Parkinson's Disease: New Insights |
| 2000 |
Robert L. Martuza, MD |
Conditional Replicating Herpes Vectors for Tumor Therapy |
| 2000 |
Justin McArthur, MBBS, MPH |
HIV, Dementia, and The Big, Bad Macrophage |
| 2000 |
John Reed, MD, PhD |
Mechanisms of Apoptosis |
Back to top.
Frontiers in Clinical Neuroscience
| Year |
Author |
Title of Paper |
| 2001 |
Daniel H. Lowenstein, MD |
Epiliptogenesis: Developmental Deja vu? |
| 2001 |
Clifford B. Saper, MD, PhD |
To Sleep, Perchance to Dream: Control of Consciousness and Sleep States |
| 2001 |
Stephen M. Strittmatter, MD, PhD |
CNS Axon Regeneration and Nogo |
| 2001 |
Elizabeth Touronier-Lasserve, MD |
CADASIL, from Patients to the NOTCH3 Gene and Back to Patients |
| 2002 |
Emmanuel Mignot, MD, PhD |
Sleep, Hypocretins and Narcolepsy |
| 2002 |
Mel B. Feany, MD, PhD |
Learning About Human Neurodegenerative Diseases from Flies and Worms |
| 2002 |
Claudia Lucchinetti, MD |
Unraveling the Mystery of the Multiple Sclerosis Lesion: Pathogenic Clues and Therapeutic Hints |
| 2002 |
Ronald D. McKay, PhD |
From Stem Cells to Circuits in the Mammalian Nervous System |
| 2003 |
J. Gregory Cairncross, MD |
Managing Glioma in the Molecular Era |
| 2003 |
Christopher A. Walsh, MD, PhD |
Genes that Control the Shape and Size of the Human Cerebral Cortex |
| 2003 |
Robert Brown, Jr., MD, DPhil |
Amyotropic Lateral Sclerosis: Recent Approaches to Biology and Therapy |
| 2003 |
Bruce L. Miller, MD |
Portraits of Artists: Emergence of Visual Creativity in Dementia |
| 2004 |
Kevin P. Campbell, PhD |
Molecular Basis of Muscular Dystrophy |
| 2004 |
Robert B. Darnell, MD, PhD |
The Emerging Importance of RNA Regulation in Neurological Disease: Its Role in Paraneoplastic Syndromes and Fragile-X Mental Retardation |
| 2004 |
Richard M. Ransohoff, MD |
What Can Chemokines Do To (and for) My Patients? |
| 2004 |
Lennart Mucke, MD |
Markers and Mediators of Neuronal Deficits in Dementia |
| 2005 |
Charles A. Thornton, MD |
RNA-Mediated Neurological Diseases |
| 2005 |
Valina L. Dawson, PhD |
Harnessing the Neuroprotective Power of the Brain |
| 2005 |
David A. Lewis, MD |
Cognitive Dysfunction in Schizophrenia: Pathophysiological Mechanisms and Treatment Interventions |
| 2005 |
Steven S. Scherer, MD, PhD |
Finding the Causes of Inherited Neuropathies |
| 2006 |
Louis J. Ptacek, MD |
Genetics of the Human Clock |
| 2006 |
Jerry R. Mendell, MD |
Gene Therapy for Muscular Dystrophy: Fulfilling the Prophecy? |
| 2006 |
Vanda A. Lennon, MD, PhD |
Changing Concepts in CNS Demyelinating Disorders: Autoimmune Water Channelopathies |
| 2006 |
Don W. Cleveland, PhD |
From Charcot to Lou Gehrig: Mechanisms of Motor Neuron Death in ALS |
| 2007 |
Anthony E. Lang, MD |
Parkinson's Disease: Beyond the Decade of the Brain |
| 2007 |
Michael A. Moskowitz, MD |
Channels, Genes, Hormones, and Migraine |
| 2007 |
Christine Van Broeckhoven, PhD, DSc |
The Alzheimer-Frontotemporal Spectrum: A Molecular Approach |
| 2007 |
Phillip A. Low, MD |
Autonomic Neuropathy: Progress in Pathogenesis and Treatment |
| 2008 |
Moses Rodriguez, MD |
Natural Autoantibodies in the Treatment of Neurological Disease |
| 2008 |
Kristine Yaffe, MD |
Prevention of Dementia in 2008: Strategies from Epidemiological Studies |
| 2008 |
Harry T. Orr, PhD |
Protein Interactions and Cell Signaling Pathways in SCA1 Pathogenesis: Targets for Therapeutics |
| 2008 |
Ann M. Graybiel, PhD |
Learning and Memory Mechanisms of the Basal Ganglia |
Back to top.
Hot Topics Plenary Session
| Year |
Presenter |
Title of Paper |
| 2006 |
William E. Klunk, MD, PhD |
Imaging the Pathology of Alzheimer's Disease with Pittsburgh Compound-B |
| 2006 |
Ralph L. Sacco, MD, MS |
Cholesterol, Statins, and Stroke |
| 2006 |
Demetrius M. Maraganore, MD |
Complex Genetics of Parkinson's Disease: Beyond Linkage Analysis |
| 2006 |
Paul S. Mischel, MD |
Targeting EGFR in Glioblastoma: How Molecular Analysis May Potentially be Used to Identify Patients Who are Likely to Benefit |
| 2007 |
John P. Donoghue, MD |
Neural Interfaces to Restore Function |
| 2007 |
Michael Hutton, PhD |
Progranulin Mutations in FTDP-17: Genetic and Clinical Implications |
| 2007 |
Clifford B. Saper, MD, PhD |
Waking Up to Sleep: Implications for Neurology |
| 2007 |
Marinos C. Dalakas, MD |
Inhibition of B Cell Functions: Implications for Neurology |
| 2008 |
Jose B. Cibelli, DVM, MD |
Embryonic Stem Cells With No Embryos |
| 2008 |
D. James Surmeier, PhD |
Calcium and Neurodegeneration in Parkinson's Disease |
| 2008 |
Jeffrey H. Kordower, PhD |
Animals Activists' Activity and Their Effect on Neuroscience Research: What Investigators Need to Know to Protect Themselves |
| 2008 |
John W. Krakauer, MD |
Constraint-Induced Movement Therapy: What is it Doing? |
Back to top.
Contemporary Clinical Issues
| Year |
Presenter |
Discussant |
Title of Presentation |
| 2001 |
Pierluigi Gambetti, MD |
Raymond P. Roos, MD |
Prior Diseases and Contaminated Beef |
| 2001 |
J. P. Mohr, MS, MD |
Vladimir Hachinski, MD |
Clinical Trials in Stroke |
| 2001 |
Samuel Wiebe, MD |
Susan S. Spencer, MD |
Is Temporal Lobe Epilepsy a Surgical Disease? |
| 2001 |
Howard M. Chertkow, MD |
Steven T. DeKosky, MD |
Just Forgetfulness or Onset of Alzheimer's Disease? |
| 2002 |
Maj. Gen. Perry M. Smith, USAF |
|
The War Against Terrorism: What to Expect, What You Can Do |
| 2002 |
Carol S. North, MD, MPE |
|
Neuropsychiatric Effects of Terrorism |
| 2002 |
Jonathan Newmark, MD |
|
Chemical Warfare Agents: What Neurologists Should Know |
| 2002 |
Larry E. Davis, MD |
|
Biological Warfare Agents: What Neurologists Should Know |
| 2002 |
Steven P. Ringel, MD |
|
The Role of the AAN in Fighting Terrorism |
| 2003 |
Diane E. Griffin, MD |
|
Neurologic Complications of Smallpox Vaccination |
| 2003 |
Pariwat Thaisetthawatkul, MD |
Joseph R. Berger, MD |
Peripheral Neuropathy Following Gastric Bypass Surgery |
| 2003 |
Lara E. Jeha, MD |
Kenneth L. Tyler, MD |
West Nile Virus: The 21st Century Polio? |
| 2003 |
Pierre Fayad, MD |
Ralph Sacco, MD |
Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy: The Sapphire Study |
| 2004 |
P. James B. Dyck, MD |
John W. Griffin, MD |
Targeted Fascicular Biopsy of Proximal Nerves with MRI Abnormality May Be Diagnostically Informative |
| 2004 |
Gregory W. Albers, MD |
S. Clay Johnston, MD, PhD |
Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran in Patients with Nonvalvular Atrial Fibrillation (SPORTIF V) |
| 2004 |
Yusei Shiga, MD |
James A. Mastrianni, MD, PhD |
Superiority of Diffusion-Weighted MRI for Depicting the Lesions Related to Creutzfeldt-Jakob Disease |
| 2005 |
Catherine Lomen-Hoerth, MD, PhD |
Hiroshi Mitsumoto, MD |
Establishing Subtypes of the Continuum of Frontal Lobe Impairment in ALS |
| 2005 |
Joachim F. Wernicke, MD, PhD |
Michael J. Polydefkis, MD |
A Double-Blind, Multi-Center Trial Comparing Duloxetine with Placebo in the Treatment of Diabetic Peripheral Neuropathic Pain |
| 2005 |
Leon J. Thal, MD |
David S. Knopman, MD |
Cognitive Effects of Donepezil and Vitamin E in Mild Cognitive Impairment |
| 2006 |
Rose Marie Mathew, MD |
Kurt A. Jaeckle,MD |
Orchiectomy for Suspected Microscopic Tumor in Patients with Paraneoplastic Anti-Ma2 Encephalitis |
| 2006 |
Tobias Kurth, MD |
Richard B. Lipton, MD |
Migraine with Aura is Associated with Increased Risk of Coronary Heart Disease in Apparently Healthy Women |
| 2006 |
Valerie Voon, MD |
Oksana Suchowersky, MD |
The Prevalence of Pathological Gambling, Hypersexuality, and Compulsive Shopping in Parkinson's Disease: A Prospective Study |
| 2007 |
Sudha Seshadri, MD |
John A Hardy, PhD |
Genetic Correlates of Brain Aging on MRI and Cognitive Test Measures: Genome-Wide Association Analyses in the Framingham Heart Study |
| 2007 |
Max Albert Hietala, MD, PhD |
James P. Kelly, MD |
The Neurochemical Aftermath of Amateur Boxing |
| 2007 |
Larry B. Goldstein, MD |
Bruce I. Ovbiagele, MD/ Jeffrey Saver, MD |
Secondary Analysis of Hemorrhagic Stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study |
| 2008 |
Michael D. Kaufman, MD |
Jeffrey A. Cohen, MD |
A Phase 2 Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study of Subcutaneous Daclizumab, a Humanized Anti-CD-25 Monoclonal Antibody, in Patients with Active, Relapsing Forms of Multiple Sclerosis – Week 44 Results |
| 2008 |
Robert H. Baloh, MD, PhD |
Virginia M-Y. Lee, PhD |
TDP-43 Mutation in Familial Motor Neuron Disease |
| 2008 |
James A. Russell, DO |
Michael A. Williams, MD |
Sedation for the Imminently Dying: Survey Results from the AAN Ethics Section |
Back to top.
Contemporary Clinical Issues Case Studies
| Year |
Presenter |
Title |
| 2004 |
Stephen L. Hauser, MD |
Multiple Sclerosis: Early Diagnosis and Early Treatment |
| 2004 |
Kathleen M. Shannon, MD |
Neuroprotection in Parkinson's Disease: Reality or Myth? |
| 2004 |
Victor W. Henderson, MD |
Estrogen in Neurologic Disease: Risk or Benefit? |
| 2005 |
Christine Klein, MD |
The Genetics of Parkinson's Disease |
| 2005 |
John W. Henson, MD |
The Treatment of Glioblastoma Multiforme (GBM) |
| 2005 |
Kyra J. Becker, MD |
The Spectrum of Recently FDA Approved Devices for the Management of Stroke Disorders |
| 2006 |
Berge A. Minassian, MD |
Lafora Disease and How an Ancient Prokaryotic Sequence Protects Us Against Starch on the Brain |
| 2006 |
Paul J. Hagerman, MD, PhD |
From Neurodevelopment to Neurodegeneration: An Older Face of the Fragile X Gene |
| 2006 |
Jeffrey L. Saver, MD |
Can this Brain Be Saved? Optimizing Acute Stroke Management with Penumbra and Vessel Imaging |
| 2007 |
C. Geoffrey Woods, MD |
Sodium Channels as Targets for Pain Management: Lessons from Inherited Pain Syndromes |
| 2007 |
Kenneth H. Fischbeck, MD |
Idebenone Treatment for Friedrich's Ataxia |
| 2007 |
J. D. Bartleson, MD |
How Should We Treat the Patient with Persistent Painful Lumbosacral Radiculopathy? |
| 2008 |
Patrick Y. Wen, MD |
Novel Antiangiogenic Therapy in Neuro-oncology |
| 2008 |
Juliane Winkelmann, MD |
Restless Legs Syndrome: New Perspectives |
| 2008 |
Marc I. Chimowitz, MD |
Symptomatic Intracranial Arterial Stenosis: Is Stenting Ready for Prime Time? |
Back to top.
Kevin Heinz
Manager, Scientific Programs
kheinz@aan.com
(651) 695-2773
|
|